Oxford BioMedica PLC buy melinda
Start price
22.09.10
/
50%
€3.00
Target price
22.03.11
€4.50
Performance (%)
-41.67%
End price
22.03.11
€1.75
Summary
This prediction ended on 22.03.11 with a price of €1.75. Massive losses of -41.67% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Oxford BioMedica PLC | -4.233% | -4.233% | 96.739% | 79.208% |
| iShares Core DAX® | 1.301% | -1.386% | 12.259% | 59.752% |
| iShares Nasdaq 100 | 0.612% | -4.172% | 1.687% | 86.147% |
| iShares Nikkei 225® | 8.772% | 9.777% | 30.041% | 63.047% |
| iShares S&P 500 | 0.254% | -2.301% | 0.794% | 57.981% |
Comments by melinda for this prediction
In the thread Oxford BioMedica PLC diskutieren
Biopharma-
Oxford BioMedica ist ein biopharmazeutisches Unternehmen in der Entwicklung und Kommerzialisierung von innovativen Gen-basierter Medikamente spezialisiert
(Laufzeit überschritten)